Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project

Fig. 1

Kaplan-Meier estimate for proportion of children with virological failure. Risk of failure in children harboring virus fully “susceptible” to cART (black continuous line) versus risk of failure in children with virus “resistant” to at least one drug (red continuous line) (Log-rank test: P = 0.0954). The dotted lines correspond to 95 % confidence intervals. In total, 21 patients stopped cART between cART initiation and 6 months of follow-up and were censored at cART stop. This explains why at 6 months there are 427 participants at risk in the no PDR/PDR and susceptible group and 28 participants at risk in the PDR and resistant group

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us